Compass Therapeutics Files Annual Report
Ticker: CMPX · Form: ARS · Filed: Apr 29, 2026 · CIK: 0001738021
| Field | Detail |
|---|---|
| Company | Compass Therapeutics, Inc. (CMPX) |
| Form Type | ARS |
| Filed Date | Apr 29, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, sec-filing, company-update
TL;DR
Compass Therapeutics filed its 2025 ARS on 4/29/26. Check it for financials.
AI Summary
Compass Therapeutics, Inc. filed its Annual Report to Security Holders (ARS) on April 29, 2026, for the period ending December 31, 2025. The company is based in Boston, MA, and its fiscal year ends on December 31st. This filing provides a comprehensive overview of the company's performance and financial standing for the reporting year.
Why It Matters
This filing provides shareholders and potential investors with crucial information about Compass Therapeutics' financial health and operational performance over the past fiscal year.
Risk Assessment
Risk Level: low — This is a routine annual report filing and does not contain new material events or significant financial changes.
Key Players & Entities
- Compass Therapeutics, Inc. (company) — Filer
- 0001738021 (company) — CIK Number
- 001-39696 (company) — File Number
- 2026-04-29 (date) — Filing Date
- 2025-12-31 (date) — Period of Report
- 80 GUEST STREET BOSTON MA 02135 (address) — Mailing and Business Address
FAQ
What is the filing date of the ARS?
The ARS was filed on April 29, 2026.
What period does this Annual Report to Security Holders cover?
The period of report is December 31, 2025.
What is the CIK number for Compass Therapeutics, Inc.?
The CIK number for Compass Therapeutics, Inc. is 0001738021.
Where is Compass Therapeutics, Inc. located?
Compass Therapeutics, Inc. is located at 80 GUEST STREET BOSTON MA 02135.
What is the SIC code for Compass Therapeutics, Inc.?
The SIC code for Compass Therapeutics, Inc. is 2836 Biological Products, (No Diagnostic Substances).
Filing Details
This Form ARS (Form ARS) was filed with the SEC on April 29, 2026 regarding Compass Therapeutics, Inc. (CMPX).